Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:APRE NASDAQ:BON NASDAQ:MTEX NASDAQ:SHPH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPREAprea Therapeutics$0.67-5.7%$0.79$0.55▼$2.22$8.79M1.583,095 shs22,852 shsBONBon Natural Life$1.16$1.24$1.10▼$3.40$9.43M-0.178,094 shs10,649 shsMTEXMannatech$4.25$5.09$3.80▼$12.45$8.20M0.7212,245 shs1,617 shsSHPHShuttle Pharmaceuticals$3.03-4.1%$4.49$2.71▼$55.90$2.01M0.296.02 million shs2.55 million shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAPREAprea Therapeutics-1.62%-7.34%-6.43%-26.26%-59.70%BONBon Natural Life0.00%0.00%-4.92%-14.07%-17.73%MTEXMannatech0.00%-10.34%-21.59%-12.55%-45.72%SHPHShuttle Pharmaceuticals-4.11%+2.36%-12.43%-70.00%-92.05%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPREAprea Therapeutics$0.67-5.7%$0.79$0.55▼$2.22$8.79M1.583,095 shs22,852 shsBONBon Natural Life$1.16$1.24$1.10▼$3.40$9.43M-0.178,094 shs10,649 shsMTEXMannatech$4.25$5.09$3.80▼$12.45$8.20M0.7212,245 shs1,617 shsSHPHShuttle Pharmaceuticals$3.03-4.1%$4.49$2.71▼$55.90$2.01M0.296.02 million shs2.55 million shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAPREAprea Therapeutics-1.62%-7.34%-6.43%-26.26%-59.70%BONBon Natural Life0.00%0.00%-4.92%-14.07%-17.73%MTEXMannatech0.00%-10.34%-21.59%-12.55%-45.72%SHPHShuttle Pharmaceuticals-4.11%+2.36%-12.43%-70.00%-92.05%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAPREAprea Therapeutics 2.40Hold$4.07507.87% UpsideBONBon Natural Life 1.00SellN/AN/AMTEXMannatech 1.00SellN/AN/ASHPHShuttle Pharmaceuticals 1.00SellN/AN/ACurrent Analyst Ratings BreakdownLatest SHPH, BON, MTEX, and APRE Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/17/2026APREAprea Therapeutics Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)7/17/2026MTEXMannatech Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)7/17/2026SHPHShuttle Pharmaceuticals Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (E+) ➝ Sell (E)7/1/2026MTEXMannatech Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)6/30/2026SHPHShuttle Pharmaceuticals Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E) ➝ Sell (E+)6/26/2026BONBon Natural Life Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D)6/15/2026SHPHShuttle Pharmaceuticals Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (E+) ➝ Sell (E)6/11/2026MTEXMannatech Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)6/1/2026SHPHShuttle Pharmaceuticals Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E) ➝ Sell (E+)5/26/2026MTEXMannatech Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)5/18/2026SHPHShuttle Pharmaceuticals Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (E+) ➝ Sell (E)(Data available from 7/21/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAPREAprea Therapeutics$290K28.56N/AN/A$1.52 per share0.44BONBon Natural Life$18.67M0.51N/AN/A$7.13 per share0.16MTEXMannatech$108.04M0.08N/AN/A($2.75) per share-1.55SHPHShuttle PharmaceuticalsN/AN/AN/AN/A$11.14 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAPREAprea Therapeutics-$12.60M-$1.54N/AN/AN/A-4,405.59%-61.03%-50.24%8/11/2026 (Estimated)BONBon Natural Life-$2MN/AN/AN/AN/AN/AN/AN/AN/AMTEXMannatech-$15.21M-$6.71N/AN/AN/A-11.97%-2,383.34%-40.24%N/ASHPHShuttle Pharmaceuticals-$11.72M-$47.70N/AN/AN/AN/A-408.34%-138.15%N/ALatest SHPH, BON, MTEX, and APRE EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/11/2026Q2 2026APREAprea Therapeutics-$0.23N/AN/AN/A$0.25 millionN/A5/14/2026Q4 2025MTEXMannatechN/A$0.49N/A$0.49N/A$24.92 million5/13/2026Q1 2026APREAprea Therapeutics-$0.23-$0.22+$0.01-$0.22$0.00 millionN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthAPREAprea TherapeuticsN/AN/AN/AN/AN/ABONBon Natural LifeN/AN/AN/AN/AN/AMTEXMannatechN/AN/A-100.00%N/AN/ASHPHShuttle PharmaceuticalsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAPREAprea TherapeuticsN/A8.928.92BONBon Natural LifeN/AN/AN/AMTEXMannatechN/A1.090.59SHPHShuttle PharmaceuticalsN/A0.300.30Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAPREAprea Therapeutics34.19%BONBon Natural Life0.57%MTEXMannatech12.98%SHPHShuttle Pharmaceuticals4.58%Insider OwnershipCompanyInsider OwnershipAPREAprea Therapeutics10.49%BONBon Natural Life26.48%MTEXMannatech47.50%SHPHShuttle Pharmaceuticals12.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAPREAprea Therapeutics712.38 million11.08 millionNo DataBONBon Natural Life1008.13 million5.98 millionN/AMTEXMannatech2501.93 million1.01 millionNot OptionableSHPHShuttle Pharmaceuticals5640,000557,000Not OptionableSHPH, BON, MTEX, and APRE HeadlinesRecent News About These CompaniesFinancial Lp Hrt Purchases 8,266 Shares of Shuttle Pharmaceuticals (NASDAQ:SHPH) StockJuly 15, 2026 | americanbankingnews.comShuttle Pharmaceuticals (NASDAQ:SHPH) Major Shareholder Buys 8,266 SharesJuly 14, 2026 | insidertrades.comShuttle Pharmaceuticals (NASDAQ:SHPH) Major Shareholder Sells $65,229.12 in StockJuly 12, 2026 | americanbankingnews.comFinancial Lp Hrt Sells 10,580 Shares of Shuttle Pharmaceuticals (NASDAQ:SHPH) StockJuly 11, 2026 | americanbankingnews.comShuttle Pharmaceuticals (NASDAQ:SHPH) Major Shareholder Financial Lp Hrt Sells 10,580 Shares of StockJuly 10, 2026 | insidertrades.comShuttle Pharmaceuticals (NASDAQ:SHPH) Major Shareholder Acquires 7,851 Shares of StockJuly 8, 2026 | insidertrades.comShuttle Pharmaceuticals (NASDAQ:SHPH) Major Shareholder Financial Lp Hrt Purchases 3,959 SharesJuly 3, 2026 | insidertrades.comShuttle Pharmaceuticals (NASDAQ:SHPH) Major Shareholder Financial Lp Hrt Purchases 6,755 Shares of StockJuly 2, 2026 | insidertrades.comUnited Dogecoin Advances Low-Cost Mining and Data InfrastructureJuly 1, 2026 | tipranks.comSHPH Share News TodayJune 26, 2026 | uk.investing.comShuttle Pharma's United Dogecoin eyes multiple revenue streams with AI data centersJune 26, 2026 | msn.comUnited Dogecoin Purchases Dogecoin Miners and Secures Renewable Energy Data Centre SiteJune 26, 2026 | newsfilecorp.comNUnited Dogecoin Advances Data Centre and Power Infrastructure Strategy to Support DOGE Mining and AI HostingJune 25, 2026 | newsfilecorp.comNShuttle Pharmaceuticals Announces Planned Reverse Stock SplitJune 11, 2026 | tipranks.comShuttle Pharma Announces Reverse Stock Split will Become Effective on June 11, 2026, at 12:01 a.m., Eastern TimeJune 9, 2026 | newsfilecorp.comNShuttle Pharmaceuticals Holdings Inc SHPHMay 19, 2026 | morningstar.comMShuttle Pharmaceuticals Holdings, Inc.May 15, 2026 | edition.cnn.comShuttle Pharmaceuticals and United Dogecoin Announce Purchase Order for up to 3,000 ElphaPex Dogecoin and Litecoin Mining RigsMay 14, 2026 | newsfilecorp.comNShuttle Pharmaceuticals Completes Merger and PIPE FinancingMay 7, 2026 | tipranks.comE.F. Hutton & Co. Serves as Exclusive M&A Advisor and Placement Agent on Completed Shuttle Pharmaceuticals–United Dogecoin Merger to Create the Largest Public Dogecoin MinerMay 7, 2026 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesSK Hynix’s Nasdaq Listing Could Reset the AI Memory TradeBy Thomas Hughes | July 7, 2026Amazon’s New Debt Deal Puts Its AI Spending Story on TrialBy Jeffrey Neal Johnson | July 10, 2026As Inflation Hits 3-Year High, These 2 ETFs Are Designed to Hedge Against Rising CostsBy Jessica Mitacek | June 23, 2026The Bond Market Just Sent Amazon a Message Investors Shouldn’t IgnoreBy Sam Quirke | July 14, 2026Amazon’s AI Spending Is About to Face Its Most Important AWS Test YetBy Sam Quirke | July 20, 2026SHPH, BON, MTEX, and APRE Company DescriptionsAprea Therapeutics NASDAQ:APRE$0.67 -0.04 (-5.71%) Closing price 07/20/2026 04:00 PM EasternExtended Trading$0.67 0.00 (-0.45%) As of 07/20/2026 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways. Its lead product candidate is the ATRN-119 that is in Phase I clinical trials for treating advanced solid tumors. The company is also developing ATRN-1051 for the treatment of ovarian cancer; and APRE-DDRi for the treatment of advanced solid tumors. The company is headquartered in Doylestown, Pennsylvania.Bon Natural Life NASDAQ:BON$1.16 0.00 (0.00%) Closing price 07/20/2026 03:47 PM EasternExtended Trading$1.15 -0.01 (-0.86%) As of 07/20/2026 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Bon Natural Life Limited, together with its subsidiaries, engages in the research and development, manufacture, and sale of functional active ingredients extracted from natural herb plants in the People's Republic of China and internationally. The company provides personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers; natural health supplements comprising powder drinks and bioactive food ingredient products primarily used as food additives; and nutritional supplements. Its products are principally used by manufacturer customers in the functional food, personal care, cosmetic, and pharmaceutical industries. The company was founded in 2006 and is headquartered in Grand Cayman, the Cayman Islands.Mannatech NASDAQ:MTEX$4.25 0.00 (0.00%) As of 07/20/2026 12:02 PM EasternMannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels. Mannatech, Incorporated was incorporated in 1993 and is headquartered in Flower Mound, Texas.Shuttle Pharmaceuticals NASDAQ:SHPH$3.03 -0.13 (-4.11%) Closing price 07/20/2026 04:00 PM EasternExtended Trading$3.42 +0.39 (+12.77%) As of 07/20/2026 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to cure cancers. It develops Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas SP-1-161, an HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway for radiation sensitizing cancer cells and protecting normal cells; SP-2-225, a pre-clinical class IIb that effects on the regulation of the immune system; and SP-1-303, a pre-clinical selective Class I HDAC for the treatment of ER positive cancers . The company is based in Gaithersburg, Maryland. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino's Stock Serving Up a Buying Opportunity? AI Data Centers Need Power, and These 2 Industrials Are Cashing In 5 Stocks Quietly Trading Near All-Time Highs While Everyone Watches the AI Drama Meta Platforms Turns AI Power Scarcity Into a $10 Billion Cloud Bet Why Gold Miners Could Be the Market's Biggest Comeback Story A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Amazon’s AI Spending Is About to Face Its Most Important AWS Test Yet Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
